Paper35459727
Heart valve disease: a journey of discovery.
Dobson LE and 1 other. Heart, 2022. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Heart valve disease: a journey of discovery. Papers, record 35459727. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35459727
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aortic Valve Stenosis | Major topic |
| Heart Valve Diseases | Major topic |
| Heart Valve Prosthesis | Major topic |
| Heart Valve Prosthesis Implantation | Major topic |
| Transcatheter Aortic Valve Replacement | Major topic |
| Aortic Valve | |
| Artificial Intelligence | |
| Heart Valves | |
| Humans | |
| Treatment Outcome |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41246017 | Application of transesophageal echocardiography combined with FloTrac monitoring in cardiac valve replacement surgery. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/41246017 | PubMed |
| 40837350 | Effects of improved ultrafiltration on serum level of IL-6 and TNF-a, HCT, and cardiopulmonary function in patients with extracorporeal circulation in valve replacement. | J Med Biochem | 2025 | https://conductscience.org/library/papers/40837350 | PubMed |
| 40720250 | Effects of Esketamine Combined With Remimazolam Tosylate on Hemodynamics During Cardiovascular Anesthesia. | Clin Transl Sci | 2025 | https://conductscience.org/library/papers/40720250 | PubMed |
| 39780165 | Application of low-intensity anticoagulation after On-X mechanical aortic valve replacement. | J Cardiothorac Surg | 2025 | https://conductscience.org/library/papers/39780165 | PubMed |
| 39411568 | Exploring the Well-being Experiences of Patients Following Heart Valve Replacement Surgery through the Biopsychosocial-spiritual Model: A Qualitative Content Analysis. | Int J Community Based Nurs Midwifery | 2024 | https://conductscience.org/library/papers/39411568 | PubMed |
| 39221196 | Recent advancements in polymeric heart valves: From basic research to clinical trials. | Mater Today Bio | 2024 | https://conductscience.org/library/papers/39221196 | PubMed |
| 38136208 | Natural Substances vs. Approved Drugs in the Treatment of Main Cardiovascular Disorders-Is There a Breakthrough? | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/38136208 | PubMed |
| 37053279 | Cardiovascular Calcification Heterogeneity in Chronic Kidney Disease. | Circ Res | 2023 | https://conductscience.org/library/papers/37053279 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35459727
GET https://conductscience.org/api/papers/v1/35459727/authors